Companies: 10,795·Total market cap: $144.5T
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMONYSEHealthcare● Active
$472.80
$-9.23(-1.91%)
Market Cap$175.7B
P/E Ratio—
52W High$643.99
52W Low$385.46
Cash on HandFinancialsRevenue

Thermo Fisher Scientific Inc. (TMO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

TMO · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$10.11B▲ +81.2% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$9.86B
cashAndCashEquivalents
Short-Term Investments
$253.0M
shortTermInvestments
YoY Change vs Prior Year
+81.2%
vs prior fiscal year
Latest Quarter
$3.26B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$10.11BCash on Hand
Total Debt$40.85BTotal Debt
Net Cash / Net Debt−$30.75BNet Debt Position
Cash vs Debt Ratio
Cash 20%Debt 80%

Thermo Fisher Scientific Inc. carries a net debt position of $30.75B. Total debt ($40.85B) exceeds cash on hand ($10.11B). Thermo Fisher Scientific Inc. cash vs debt ratio: 20% cash / 80% debt.

Net Cash = Cash & ST Investments − Total Debt$10.11B − $40.85B = −$30.75B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
TMO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$10.11B+81.2%
Dec 31, 2024$5.58B-31.0%
Dec 31, 2023$8.08B-5.2%
Dec 31, 2022$8.52B+90.4%
Dec 31, 2021$4.48B-56.6%
TMO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.YOU
TMO
$10.11B5.8%
#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Thermo Fisher Scientific Inc. (TMO) cash on hand as of December 31, 2025 is $10.11B, comprising $9.86B in cash and cash equivalents (CCE) plus $253.0M in short-term investments — reported as Thermo Fisher Scientific Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Thermo Fisher Scientific Inc. cash reserves or cash position.

Thermo Fisher Scientific Inc. annual cash on hand history shows increased +81.2% in 2025: increased +81.2% in 2025. Thermo Fisher Scientific Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Thermo Fisher Scientific Inc. carries total debt of $40.85B against cash of $10.11B, resulting in a net debt position of -$30.75B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

TMO cash on hand · 5 questions

As of December 31, 2025, Thermo Fisher Scientific Inc. (TMO) has $10.11B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $9.86B in cash and cash equivalents (CCE) plus $253,000,000 in short-term investments. Latest quarter (March 28, 2026): $3.26B. Data sourced from the annual 10-K filing via FMP.

TMO cash on handTMO cash reservesTMO cash 2025how much cash does TMO have

▸ Source: FMP /balance-sheet-statement · US GAAP · Thermo Fisher Scientific Inc. · Thermo Fisher Scientific Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025